Regeneron moves to phase three of Covid treatment trials

Company hiring 400 staff in Limerick to increase capacity

Niall O’Leary, Site Head at Regeneron; Tánaiste Leo Varadkar; An Taoiseach Micheál Martin; and Mary Buckley Executive Director IDA at the recent jobs announcement. Picture: Cathal Noonan

Researchers will start testing an antibody cocktail developed by Regeneron in a key trial of possible Covid-19 treatments.

The biopharmaceutical company is adding more than 400 new jobs to its industrial operations facility in Limerick in order to maximise capacity at its New York facility to produce large quantities of the Covid treatment.